StoxRadar is free — only 218 spots left in beta.

SPY$777.22-0.24%QQQ$757.73-0.25%DIA$511.02-0.69%IWM$277.70-1.29%AAPL$336.67+0.91%MSFT$529.76+0.09%NVDA$237.47-0.74%AMZN$259.92+1.42%GOOGL$350.50+0.81%META$721.31-2.38%TSLA$377.81-0.75%JPM$329.58-0.51%GLD$375.88-1.67%BTC$36.88-2.54%IBIT$47.21-2.64%SPY$777.22-0.24%QQQ$757.73-0.25%DIA$511.02-0.69%IWM$277.70-1.29%AAPL$336.67+0.91%MSFT$529.76+0.09%NVDA$237.47-0.74%AMZN$259.92+1.42%GOOGL$350.50+0.81%META$721.31-2.38%TSLA$377.81-0.75%JPM$329.58-0.51%GLD$375.88-1.67%BTC$36.88-2.54%IBIT$47.21-2.64%

StoxRadar is free.

PMI

PMI

AMEX

Picard Medical, Inc.

Healthcare · Medical - Devices

$9.37
+0.63+7.21%
Day Range: $7.63 – $10.19
Market Cap
$19.30M
Volume
790,505
52W High
$684.00
52W Low
$2.65
P/E Ratio
-0.46
EPS (TTM)
$-15.08
Div Yield
—
Beta
-2.64

Price History

08-2609-0309-1409-2209-30$2$4$6$8$10

Picard Medical, Inc., through its associated companies, is dedicated to the entire process of medical device commercialization, from initial design and manufacturing to production, distribution, marketing, and sales. A key product in its portfolio is the SynCardia TAH, a sophisticated total artificial heart specifically engineered to supplant a failing human heart in individuals afflicted with advanced cardiac disease. The firm's market presence extends across the United States, Europe, and other international regions. Established in 2021, Picard Medical maintains its primary operations in Tucson, Arizona, functioning as a direct subsidiary of Hunniwell Picard I, Llc.

CEO
Richard Fang
Employees
75
Headquarters
Tucson, US
IPO Date
2025-08-29
BETA

Get started for full access.